New guideline provides clinical recommendations for specific insomnia drugs

February 15, 2017, American Academy of Sleep Medicine

A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of chronic insomnia disorder.

The guideline, which is published in the Feb. 15 issue of the Journal of Clinical Sleep Medicine, provides recommendations to help clinicians choose a specific pharmacological agent for the treatment of chronic insomnia in adults, when such treatment is indicated. Developed by an expert task force and approved by the AASM board of directors, the guideline was based on a systematic literature review, meta-analyses, and assessment of the evidence using the GRADE methodology. A draft of the guideline was previously made available for public comment.

"The publication of this is an important step forward for the field of ," said AASM President Ronald D. Chervin, MD, MS. "It further equips clinicians to provide high quality, patient-centered care for millions of people who suffer from chronic insomnia."

Although transient insomnia symptoms occur in 30 to 35 percent of the population, the full clinical syndrome of chronic insomnia disorder occurs in about 10 percent of people. The CDC has estimated that 4.1 percent of U.S. adults report having taken a prescription sleep aid in the past month, based on survey data collected from 2005 - 2010.

The guideline includes 14 specific recommendations for individual agents, including prescription medications such as zolpidem and eszopiclone; over-the-counter medications such as diphenhydramine; and dietary supplements such as melatonin and valerian. Each recommendation suggests whether clinicians should or should not use the individual drug for sleep onset insomnia or sleep maintenance insomnia, versus no treatment. However, the guideline does not recommend one drug over another since few comparative efficacy studies have been conducted among these agents.

The authors noted that the data available to support these recommendations is often less than certain. As a result, the strength of each recommendation is classified as "weak," reflecting a lower degree of certainty in the appropriateness of the patient-care strategy. Therefore, clinicians must continue to exercise sound clinical judgment in their care for patients with chronic insomnia. Decisions should be based not only on these recommendations but also on a clinician's experience and the individual circumstances presented by the patient.

The guideline emphasizes that medications for chronic insomnia disorder should be considered mainly in patients who are unable to participate in cognitive behavioral therapy for insomnia (CBT-I), patients who still have symptoms after this therapy, or those who require a temporary adjunct to CBT-I. A clinical guideline previously published by the American Academy of Sleep Medicine indicates that CBT-I is an effective treatment that should be utilized as an initial intervention for , and this position was reiterated by the AASM in a 2014 Choosing Wisely statement.

Anyone who is having trouble falling asleep or staying asleep should discuss the concern with a doctor. Help for an ongoing sleep problem is available from more than 2,500 sleep centers that are accredited by the American Academy of Sleep Medicine.

Explore further: New clinical guideline to help clinicians treat circadian rhythm sleep-wake disorders

More information: Michael J. Sateia et al, Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline, Journal of Clinical Sleep Medicine (2017). DOI: 10.5664/jcsm.6470

Related Stories

New clinical guideline to help clinicians treat circadian rhythm sleep-wake disorders

October 14, 2015
A new clinical practice guideline published by the American Academy of Sleep Medicine provides clinicians with updated recommendations for the treatment of intrinsic circadian rhythm sleep-wake disorders (CRSWDs).

Study finds that melatonin content of supplements varies widely

February 14, 2017
A new study suggests that the melatonin content of dietary supplements often varies widely from what is listed on the label.

Insomnia linked to higher risk of developing asthma

February 1, 2017
People experiencing insomnia symptoms have a higher risk of developing asthma, according to a new study published in the European Respiratory Journal.

Insomnia prevalent in patients with asthma

December 8, 2016
A team of researchers from the University of Pittsburgh has found that insomnia is highly prevalent in adults with asthma and is also associated with worse asthma control, depression and anxiety symptoms and other quality ...

Sleep is key to curing chronic pain

September 21, 2016
Research from the University of Warwick reveals that the way chronic pain patients think about pain and sleep leads to insomnia and poor management of pain.

Recommended for you

Placental accumulation of flame retardant chemical alters serotonin production in rats

January 22, 2018
A North Carolina State University-led research team has shown a connection between exposure to a widely used flame retardant chemical mixture and disruption of normal placental function in rats, leading to altered production ...

Marijuana use does not lower chances of getting pregnant

January 22, 2018
Marijuana use—by either men or women—does not appear to lower a couple's chances of getting pregnant, according to a new study led by Boston University School of Public Health (BUSPH) researchers.

Americans are getting more sleep

January 19, 2018
Although more than one in three Americans still don't get enough sleep, a new analysis shows first signs of success in the fight for more shut eye. According to data from 181,335 respondents aged 15 and older who participated ...

Wine is good for you—to a point

January 18, 2018
The Mediterranean diet has become synonymous with healthy eating, but there's one thing in it that stands out: It's cool to drink wine.

Sleep better, lose weight?

January 17, 2018
(HealthDay)—Sleeplessness could cost you when it's time to stand on your bathroom scale, a new British study suggests.

Who uses phone apps to track sleep habits? Mostly the healthy and wealthy in US

January 16, 2018
The profile of most Americans who use popular mobile phone apps that track sleep habits is that they are relatively affluent, claim to eat well, and say they are in good health, even if some of them tend to smoke.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.